Antimicrobial activity against Staphylococcus aureus after 24 hrs by broth microdilution method
|
Staphylococcus aureus
|
1.82
ug.mL-1
|
|
Antimicrobial activity against Streptococcus pyogenes after 24 hrs by broth microdilution method
|
Streptococcus pyogenes
|
1.8
ug.mL-1
|
|
Antimicrobial activity against Salmonella Typhimurium after 24 hrs by broth microdilution method
|
Salmonella enterica subsp. enterica serovar Typhimurium
|
1.85
ug.mL-1
|
|
Antimicrobial activity against Escherichia coli after 24 hrs by broth microdilution method
|
Escherichia coli
|
1.9
ug.mL-1
|
|
Inhibition of Helicobacter pylori invasion into human AGS cells at 2.5 uM after 6 hrs
|
Helicobacter pylori
|
90.0
%
|
|
Inhibition of Helicobacter pylori-induced inflammation in human AGS cells assessed as reduction of IL-8 production at 10 uM by ELISA
|
Helicobacter pylori
|
81.9
%
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP1A
|
Streptococcus pneumoniae
|
0.004
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP1A
|
Streptococcus pneumoniae
|
0.124
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP1A
|
Streptococcus pneumoniae
|
0.049
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP1A
|
Streptococcus pneumoniae
|
0.422
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP1A
|
Streptococcus pneumoniae
|
0.059
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP1A
|
Streptococcus pneumoniae
|
0.067
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP1A
|
Streptococcus pneumoniae
|
0.09
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP1A
|
Streptococcus pneumoniae
|
0.044
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP1A
|
Streptococcus pneumoniae
|
0.017
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP1B
|
Streptococcus pneumoniae
|
1.103
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP1B
|
Streptococcus pneumoniae
|
0.035
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP1B
|
Streptococcus pneumoniae
|
0.029
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP1B
|
Streptococcus pneumoniae
|
0.116
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP1B
|
Streptococcus pneumoniae
|
0.165
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP1B
|
Streptococcus pneumoniae
|
0.079
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP1B
|
Streptococcus pneumoniae
|
0.059
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP1B
|
Streptococcus pneumoniae
|
0.068
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP1B
|
Streptococcus pneumoniae
|
0.006
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2X
|
Streptococcus pneumoniae
|
0.117
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2X
|
Streptococcus pneumoniae
|
0.062
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2X
|
Streptococcus pneumoniae
|
0.004
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2X
|
Streptococcus pneumoniae
|
0.043
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2X
|
Streptococcus pneumoniae
|
0.018
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2X
|
Streptococcus pneumoniae
|
0.094
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2X
|
Streptococcus pneumoniae
|
0.008
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2X
|
Streptococcus pneumoniae
|
0.037
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2X
|
Streptococcus pneumoniae
|
0.022
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2A
|
Streptococcus pneumoniae
|
0.077
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2A
|
Streptococcus pneumoniae
|
0.034
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2A
|
Streptococcus pneumoniae
|
0.051
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2A
|
Streptococcus pneumoniae
|
0.066
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2A
|
Streptococcus pneumoniae
|
0.05
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2A
|
Streptococcus pneumoniae
|
0.08
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2A
|
Streptococcus pneumoniae
|
0.08
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP2B
|
Streptococcus pneumoniae
|
0.176
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP2B
|
Streptococcus pneumoniae
|
0.165
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP2B
|
Streptococcus pneumoniae
|
0.033
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP2B
|
Streptococcus pneumoniae
|
0.144
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP2B
|
Streptococcus pneumoniae
|
0.029
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP2B
|
Streptococcus pneumoniae
|
0.22
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP2B
|
Streptococcus pneumoniae
|
0.05
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP2B
|
Streptococcus pneumoniae
|
0.055
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP2B
|
Streptococcus pneumoniae
|
0.03
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 24 PBP3
|
Streptococcus pneumoniae
|
0.049
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3413 PBP3
|
Streptococcus pneumoniae
|
0.029
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 2527 PBP3
|
Streptococcus pneumoniae
|
0.022
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3676 PBP3
|
Streptococcus pneumoniae
|
0.019
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3243 PBP3
|
Streptococcus pneumoniae
|
0.006
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3665 PBP3
|
Streptococcus pneumoniae
|
0.019
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 3009 PBP3
|
Streptococcus pneumoniae
|
0.047
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1076 PBP3
|
Streptococcus pneumoniae
|
0.051
ug.mL-1
|
|
Displacement of Biocillin FL from Streptococcus pneumoniae 1077 PBP3
|
Streptococcus pneumoniae
|
0.022
ug.mL-1
|
|
Antibacterial activity against Staphylococcus aureus
|
Staphylococcus aureus
|
2.84
ug.mL-1
|
|
Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM
|
Cricetulus griseus
|
75.16
%
|
|
Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM
|
Cricetulus griseus
|
87.94
%
|
|
Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)
|
Staphylococcus aureus subsp. aureus
|
15.09
%
|
|
Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)
|
Escherichia coli
|
7.14
%
|
|
Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)
|
Klebsiella pneumoniae
|
10.29
%
|
|
Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)
|
Pseudomonas aeruginosa
|
10.8
%
|
|
Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600
|
Acinetobacter baumannii
|
22.8
%
|
|
Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630
|
Candida albicans
|
9.25
%
|
|
Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)
|
Cryptococcus neoformans
|
-2.09
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging
|
Homo sapiens
|
1.48
%
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
11.63
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.02
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.02
%
|
|